# Inflo Medical Inc.

Canonical: https://abierto.us/vendors/inflo-medical-inc-h9u2rsy3dzc3

- UEI: H9U2RSY3DZC3
- CAGE: 9RWB9
- Location: Irvine, CA
- Awards in window: 1 (5 transactions), $747,398 obligated, May 22, 2024 to August 4, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $747,398

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $747,398

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50124C00019 (definitive contract): $747,398, Barda - Aspr / Daappo / Barda DCMA. The Overall Objective of This Contract Is to Improve the Safety Metrics for Extracorporeal Membrane Oxygenation (Ecmo) Through the Reduction of Anticoagulant Usage with the Retention of Performance Through the Use of a Highly Bio-Compatible Ecmo Circ. https://www.usaspending.gov/award/CONT_AWD_75A50124C00019_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/inflo-medical-inc-h9u2rsy3dzc3.